BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33288752)

  • 41. LncRNA PVT1 promotes proliferation and invasion through enhancing Smad3 expression by sponging miR-140-5p in cervical cancer.
    Chang QQ; Chen CY; Chen Z; Chang S
    Radiol Oncol; 2019 Oct; 53(4):443-452. PubMed ID: 31626590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
    Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulation of Long Noncoding RNA LUCAT1 Suppresses the Migration and Invasion of Bladder Cancer by Targeting miR-181c-5p.
    Chen Y; Zhang W; Shen L; Kadier A; Huang J; Wang R; Wu P; Yao X
    Biomed Res Int; 2020; 2020():4817608. PubMed ID: 33282949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lnc-SNHG1 Activates the TGFBR2/SMAD3 and RAB11A/Wnt/β-Catenin Pathway by Sponging MiR-302/372/373/520 in Invasive Pituitary Tumors.
    Wang H; Wang G; Gao Y; Zhao C; Li X; Zhang F; Jiang C; Wu B
    Cell Physiol Biochem; 2018; 48(3):1291-1303. PubMed ID: 30048990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA.
    Zhan Y; Chen Z; Li Y; He A; He S; Gong Y; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):273. PubMed ID: 30419948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer.
    Luo W; Wang J; Xu W; Ma C; Wan F; Huang Y; Yao M; Zhang H; Qu Y; Ye D; Zhu Y
    Cell Death Dis; 2021 Nov; 12(11):1043. PubMed ID: 34728613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.
    Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y
    Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long noncoding RNA PEG10 facilitates bladder cancer cells proliferation, migration, and invasion via repressing microRNA-29b.
    Liang T; Wang Y; Wang Y; Wang Y
    J Cell Physiol; 2019 Nov; 234(11):19740-19749. PubMed ID: 30941768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis.
    Zhang R; Xia T
    Int J Oncol; 2017 Nov; 51(5):1460-1470. PubMed ID: 29048648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long Non-Coding RNA PCAT19 Regulates the Malignant Progression of Bladder Cancer through the miR-335-5p/IER2 Axis.
    Wang C; Jiang H
    Crit Rev Eukaryot Gene Expr; 2022; 32(8):81-94. PubMed ID: 36017918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14.
    Xiao G; Wang P; Zheng X; Liu D; Sun X
    Cell Cycle; 2019 Nov; 18(21):2972-2985. PubMed ID: 31522616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The encouraging role of long noncoding RNA small nuclear RNA host gene 16 in epithelial-mesenchymal transition of bladder cancer via directly acting on miR-17-5p/metalloproteinases 3 axis.
    Peng H; Li H
    Mol Carcinog; 2019 Aug; 58(8):1465-1480. PubMed ID: 31026378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer.
    Liu H; Chen D; Bi J; Han J; Yang M; Dong W; Lin T; Huang J
    Aging (Albany NY); 2018 Oct; 10(10):2606-2623. PubMed ID: 30312173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis.
    Fang C; Xu L; He W; Dai J; Sun F
    Cell Cycle; 2019 Dec; 18(23):3288-3299. PubMed ID: 31615303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
    Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
    Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum LUCAT1 implicates the pathogenesis of muscle-invasive bladder cancer via targeting miR-199a-5p and miR-199b-5p.
    Zhou Y; Song X; Li X; Li H; Peng Y
    J Mol Histol; 2020 Oct; 51(5):583-591. PubMed ID: 32844284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circular RNA FAM114A2 suppresses progression of bladder cancer via regulating ∆NP63 by sponging miR-762.
    Liu T; Lu Q; Liu J; Xie S; Feng B; Zhu W; Liu M; Liu Y; Zhou X; Sun W; Zhang Y; Chen X; Fang F; Guo H; Yang R
    Cell Death Dis; 2020 Jan; 11(1):47. PubMed ID: 31969560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LncRNA PVT1 regulates VEGFC through inhibiting miR-128 in bladder cancer cells.
    Yu C; Longfei L; Long W; Feng Z; Chen J; Chao L; Peihua L; Xiongbing Z; Hequn C
    J Cell Physiol; 2019 Feb; 234(2):1346-1353. PubMed ID: 30076714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.